Skip to main content

Closed

LRMR: Larimar Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-106.6%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio4.29×

Larimar Therapeutics, Inc.

LRMRNASDAQ Global Market·USD·Closed

Larimar Therapeutics, Inc.

LRMRNASDAQ·USD·Closed

$3.82

−0.13%

$3.82

−$0.01 (0.13%)

52W Range

30thpctl

Volume

0.45×avg

Mkt Cap

396.83MUSD

P/E

-1.8TTM

Div Yield

–ann

52W Range

30thpctl

Volume

0.45×avg

Market Cap

396.83MUSD

P/E Ratio

-1.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings